1-1 of 1
Yingying Ma
Close
Sort by
Journal Articles

Off-the-Shelf CD33 CAR-NK Cell Therapy for Relapse/Refractory AML: First-in-Human, Phase I Trial

Ruihao Huang, Qin Wen, Xiaoqi Wang, Hongju Yan, Yingying Ma, Wang Mai-Hong, Xiao Han, Li Gao, Lei Gao, Cheng Zhang, Xi Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 7450–7451.
https://doi.org/10.1182/blood-2022-170712
Published: 2022